Company Tagline
Accelerating access to medicines and MedTech in premium global markets, starting with Japan
Industry Category
Business Keywords
Company Description
HekaBio K.K. is dedicated to accelerating access to medicines and MedTech within premium global markets, with a primary focus on Japan and the broader Asia Pacific region. HekaBio operates as a healthcare asset in-licensing, development, and commercialization platform, striving to advance a portfolio of breakthrough therapeutic innovations that address critical healthcare needs.
Located at 1-9-15 Nihonbashimuromachi, Chikiriya Tokyo Bldg 8F, Chuo-ku, Tokyo 1030022, JP, HekaBio specializes in various therapeutic areas including CNS, Oncology, Ophthalmology, and Cardiology. The company's core strengths lie in medical device and pharmaceutical in-licensing, business development, reimbursement strategies, clinical and regulatory development, and the commercialization of cutting-edge healthcare solutions.
HekaBio K.K. is committed to improving patient outcomes by bringing world-leading healthcare solutions to the market. Our team is focused on building strong partnerships and leveraging our expertise to navigate the complexities of the healthcare landscape. We invite the management of HekaBio K.K. to create a customized and exclusive company showcase and product listing on our platform to further enhance your market presence and commercial development.
HekaBio K.K.は、日本およびアジア太平洋地域に焦点を当て、グローバル市場における医薬品および医療技術へのアクセスを加速することに専念しています。HekaBioは、医療資産のインライセンス、開発、商業化プラットフォームとして機能し、重要な医療ニーズに対応する画期的な治療イノベーションのポートフォリオを推進するよう努めています。
東京都中央区日本橋室町1-9-15、チキリヤ東京ビル8F、〒1030022に位置するHekaBioは、CNS、腫瘍学、眼科、循環器学など、さまざまな治療分野を専門としています。同社の主な強みは、医療機器および医薬品のインライセンス、事業開発、償還戦略、臨床および規制開発、最先端の医療ソリューションの商業化にあります。
HekaBio K.K.は、世界をリードする医療ソリューションを市場に投入することで、患者の転帰を改善することに尽力しています。私たちのチームは、強力なパートナーシップを構築し、専門知識を活用して、医療分野の複雑さを乗り越えることに注力しています。HekaBio K.K.の経営陣を招待して、当社のプラットフォーム上でカスタマイズされた独占的な会社ショーケースと製品リストを作成し、市場でのプレゼンスと商業開発をさらに強化してください。
Key Personnel / Employees
Compare Companies Side by Side
Compare HekaBio K.K. with 3 companies in Biotechnology-Research
| Comparison Field |
HekaBio K.K.Main Company |
ViatrisView Profile |
Xcene ResearchView Profile |
The Planning ShopView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 0 | 2015 | |
|
Company Size
|
— | 10,001+ | 51-200 | 51-200 |
|
City
|
Chuo-ku, Tokyo | Pittsburgh, Pennsylvania | Ikeja , Lagos | |
|
Country
|
Japan | United States | ||
|
Skills & Keywords
Comparing with main company
|
20 Total Skills
Biotechnology
Pharmaceuticals
Medical Devices
In-Licensing
Commercialization
Healthcare Solutions
Clinical Development
CNS
Medical Device In-Licensing
Medical Device
Pharmaceutical In-Licensing
Oncology
Business Development
Reimbursement
Clinical development
Ophthalmology
Bioventure
BD&L
Regulatory development
Cardiology
|
14 Total
1 Common
13 Unique
Match
5%
Common Skills:
Healthcare Solutions
Unique Skills:
Anesthesia & Pain Management
API
Cardiovascular
Complex Products
Dermatology
Diabetes & Metabolism
+7
|
18 Total
18 Unique
Unique Skills:
Cardiovascular
Dermatology
Diabetes
Endocrinology & Metabolism
GI
Hematology
+12
|
16 Total
16 Unique
Unique Skills:
Brconsulting
Brplanning
Communications development
Hematology
Immunology
Market Landscaping
+10
|
4
Total Companies2015
Oldest Founded2
Countries63
Unique SkillsSimilar Companies
Other organizations in the same industry
Oxeia Biopharmaceuticals Inc
Biotechnology-ResearchOxeia Biopharmaceuticals develops novel therapeutics for patients with concussions. Because rest is...
Abcuro, Inc
Biotechnology-ResearchDeveloping immunotherapies for autoimmune diseases and cancer
Neuphoria Therapeutics Inc
Biotechnology-ResearchDeveloping transformative treatments for people with neuropsychiatric disorders
Alternative Company Names
This company is also known as